|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 179.1 SEK | -0.22% |
|
+5.35% | +33.96% |
| 25/04 | Transcript : Biotage AB, Q1 2024 Earnings Call, Apr 25, 2024 | |
| 25/04 | Biotage AB Approves a Dividend, Payable on May 3, 2024 | CI |
Biotage AB (publ) reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was SEK 1,566 million compared to SEK 1,232 million a year ago. Net income was SEK 268 million compared to SEK 205 million a year ago.
Basic earnings per share from continuing operations was SEK 4.06 compared to SEK 3.13 a year ago. Diluted earnings per share from continuing operations was SEK 4.04 compared to SEK 3.13 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +33.96% | 1.34B | |
| -19.42% | 18.12B | |
| -41.90% | 2.87B | |
| +19.36% | 1.9B | |
| -1.05% | 1.65B | |
| -16.83% | 957M | |
| -21.96% | 896M | |
| +7.07% | 841M | |
| +10.85% | 523M | |
| -.--% | 486M |
BIOTAGE AB 
